• Tampa General Hospital’s Cancer Institute has been recognized as one of the top cancer hospitals in the US, securing a spot in the top 3 percent nationwide, per Newsweek and Statista rankings.
• The selection process for the rankings considered recommendations from healthcare professionals, hospital managers, and patient surveys, among other factors.
• The institution was also listed among Florida’s top cancer facilities in Newsweek’s statewide list.

Tampa General Hospital (TGH) has achieved national recognition as one of the top cancer hospitals in the United States.

According to the recent rankings released by Newsweek and Statista in their America’s Best Cancer Hospitals 2023 report, TGHl Cancer Institute secured a spot in the top 3 percent of cancer hospitals nationwide. The institution was also listed among Florida’s top cancer facilities in Newsweek’s statewide list.

The selection process for the Newsweek rankings considered several factors, including a nationwide online survey that gathered recommendations from healthcare professionals, hospital managers, oncologists, hematologists, and oncology nurses who are knowledgeable about cancer care. Hospital quality metrics focusing on indicators relevant to oncology, as well as publicly available data from hospital patient surveys to analyze patient experience, were also taken into account.

“This recognition is a testament to the incredible oncology team that leads the TGH Cancer Institute to deliver world-class, cutting-edge, and compassionate cancer care,” said John Couris, president and CEO of Tampa General, who recently signed a ten-year contract extension to remain in his position through 2023. “The team is continually focused on strengthening our expertise in cancer prevention, treatment, research, education, and clinical investigations.”

TGH’s Cancer Institute has made notable developments in cancer research over the past several years through the introduction of its Bone Marrow Transplant (BMT) and Cell Therapies Unit, which specializes in treating aggressive blood cancers. Additionally, a partnership with the University of South Florida established the Health Precision Medicine Biorepository for the purpose of cancer tumor sequencing and precision medicine research.

The hospital also rolled out last year a collaborative partnership with Florida Cancer Specialists and Research Institute, which calls for its proton therapy center to be in the academic health system’s Medical and Research District adjacent to downtown Tampa.

“Another critical component of the high-quality, comprehensive cancer care we deliver at Tampa General is our commitment to academic medicine and clinical research,” said Dr. Abraham Schwarzberg, chief of Oncology, executive vice president of network development, and co-vice president of clinical and translational research. “This recognition underscores the importance of driving innovation to bring advanced testing, technology, and leading-edge treatments to cancer patients in the Tampa Bay community and beyond.”

In December, TGH’s Cancer Institute earned a three-year accreditation from the Commission on Cancer (CoC).  The hospital attained accreditation by satisfying 34 quality care requirements, providing high-quality, patient-centered cancer care via a multidisciplinary approach, and demonstrating a commitment to improving patient outcomes and quality of life for all cancer patients, according to the hospital.